Report Detail
Global Lung Disease Therapeutics Market 2023 by Company, Regions, Type and Application, Forecast to 2029
- RnM4517807 |
- 06 March, 2023 |
- Global |
- 101 Pages |
- GIR (Global Info Research) |
- Other
According to our (Global Info Research) latest study, the global Lung Disease Therapeutics market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Lung Disease Therapeutics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Disease Type and by Distribution Channel. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Lung Disease Therapeutics market size and forecasts, in consumption value ($ Million), 2018-2029
Global Lung Disease Therapeutics market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Lung Disease Therapeutics market size and forecasts, by Disease Type and by Distribution Channel, in consumption value ($ Million), 2018-2029
Global Lung Disease Therapeutics market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Lung Disease Therapeutics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Lung Disease Therapeutics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, AstraZeneca, Boehringer Ingelheim, Novartis and Mylan, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Lung Disease Therapeutics market is split by Disease Type and by Distribution Channel. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Disease Type and by Distribution Channel. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Disease Type
Asthma
Chronic Obstructive Pulmonary Disease (COPD)
Lung Cancer
Other Lung Diseases
Market segment by Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by players, this report covers
GSK
AstraZeneca
Boehringer Ingelheim
Novartis
Mylan
Vertex Pharmaceuticals
F. Hoffman La Roche
Teva Pharmaceuticals
Cipla
Fibrogen
Liminal Biosciences
PharmAkea Therapeutics
IQVIA
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Lung Disease Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Lung Disease Therapeutics, with revenue, gross margin and global market share of Lung Disease Therapeutics from 2018 to 2023.
Chapter 3, the Lung Disease Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Disease Type and application, with consumption value and growth rate by Disease Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Lung Disease Therapeutics market forecast, by regions, disease type and distribution channel, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Lung Disease Therapeutics.
Chapter 13, to describe Lung Disease Therapeutics research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Lung Disease Therapeutics
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Lung Disease Therapeutics by Disease Type
- 1.3.1 Overview: Global Lung Disease Therapeutics Market Size by Disease Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Global Lung Disease Therapeutics Consumption Value Market Share by Disease Type in 2022
- 1.3.3 Asthma
- 1.3.4 Chronic Obstructive Pulmonary Disease (COPD)
- 1.3.5 Lung Cancer
- 1.3.6 Other Lung Diseases
- 1.4 Global Lung Disease Therapeutics Market by Distribution Channel
- 1.4.1 Overview: Global Lung Disease Therapeutics Market Size by Distribution Channel: 2018 Versus 2022 Versus 2029
- 1.4.2 Hospital Pharmacies
- 1.4.3 Retail Pharmacies
- 1.4.4 Online Pharmacies
- 1.5 Global Lung Disease Therapeutics Market Size & Forecast
- 1.6 Global Lung Disease Therapeutics Market Size and Forecast by Region
- 1.6.1 Global Lung Disease Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
- 1.6.2 Global Lung Disease Therapeutics Market Size by Region, (2018-2029)
- 1.6.3 North America Lung Disease Therapeutics Market Size and Prospect (2018-2029)
- 1.6.4 Europe Lung Disease Therapeutics Market Size and Prospect (2018-2029)
- 1.6.5 Asia-Pacific Lung Disease Therapeutics Market Size and Prospect (2018-2029)
- 1.6.6 South America Lung Disease Therapeutics Market Size and Prospect (2018-2029)
- 1.6.7 Middle East and Africa Lung Disease Therapeutics Market Size and Prospect (2018-2029)
2 Company Profiles
- 2.1 GSK
- 2.1.1 GSK Details
- 2.1.2 GSK Major Business
- 2.1.3 GSK Lung Disease Therapeutics Product and Solutions
- 2.1.4 GSK Lung Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 GSK Recent Developments and Future Plans
- 2.2 AstraZeneca
- 2.2.1 AstraZeneca Details
- 2.2.2 AstraZeneca Major Business
- 2.2.3 AstraZeneca Lung Disease Therapeutics Product and Solutions
- 2.2.4 AstraZeneca Lung Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 AstraZeneca Recent Developments and Future Plans
- 2.3 Boehringer Ingelheim
- 2.3.1 Boehringer Ingelheim Details
- 2.3.2 Boehringer Ingelheim Major Business
- 2.3.3 Boehringer Ingelheim Lung Disease Therapeutics Product and Solutions
- 2.3.4 Boehringer Ingelheim Lung Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Boehringer Ingelheim Recent Developments and Future Plans
- 2.4 Novartis
- 2.4.1 Novartis Details
- 2.4.2 Novartis Major Business
- 2.4.3 Novartis Lung Disease Therapeutics Product and Solutions
- 2.4.4 Novartis Lung Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Novartis Recent Developments and Future Plans
- 2.5 Mylan
- 2.5.1 Mylan Details
- 2.5.2 Mylan Major Business
- 2.5.3 Mylan Lung Disease Therapeutics Product and Solutions
- 2.5.4 Mylan Lung Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Mylan Recent Developments and Future Plans
- 2.6 Vertex Pharmaceuticals
- 2.6.1 Vertex Pharmaceuticals Details
- 2.6.2 Vertex Pharmaceuticals Major Business
- 2.6.3 Vertex Pharmaceuticals Lung Disease Therapeutics Product and Solutions
- 2.6.4 Vertex Pharmaceuticals Lung Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 Vertex Pharmaceuticals Recent Developments and Future Plans
- 2.7 F. Hoffman La Roche
- 2.7.1 F. Hoffman La Roche Details
- 2.7.2 F. Hoffman La Roche Major Business
- 2.7.3 F. Hoffman La Roche Lung Disease Therapeutics Product and Solutions
- 2.7.4 F. Hoffman La Roche Lung Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 F. Hoffman La Roche Recent Developments and Future Plans
- 2.8 Teva Pharmaceuticals
- 2.8.1 Teva Pharmaceuticals Details
- 2.8.2 Teva Pharmaceuticals Major Business
- 2.8.3 Teva Pharmaceuticals Lung Disease Therapeutics Product and Solutions
- 2.8.4 Teva Pharmaceuticals Lung Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.8.5 Teva Pharmaceuticals Recent Developments and Future Plans
- 2.9 Cipla
- 2.9.1 Cipla Details
- 2.9.2 Cipla Major Business
- 2.9.3 Cipla Lung Disease Therapeutics Product and Solutions
- 2.9.4 Cipla Lung Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.9.5 Cipla Recent Developments and Future Plans
- 2.10 Fibrogen
- 2.10.1 Fibrogen Details
- 2.10.2 Fibrogen Major Business
- 2.10.3 Fibrogen Lung Disease Therapeutics Product and Solutions
- 2.10.4 Fibrogen Lung Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.10.5 Fibrogen Recent Developments and Future Plans
- 2.11 Liminal Biosciences
- 2.11.1 Liminal Biosciences Details
- 2.11.2 Liminal Biosciences Major Business
- 2.11.3 Liminal Biosciences Lung Disease Therapeutics Product and Solutions
- 2.11.4 Liminal Biosciences Lung Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.11.5 Liminal Biosciences Recent Developments and Future Plans
- 2.12 PharmAkea Therapeutics
- 2.12.1 PharmAkea Therapeutics Details
- 2.12.2 PharmAkea Therapeutics Major Business
- 2.12.3 PharmAkea Therapeutics Lung Disease Therapeutics Product and Solutions
- 2.12.4 PharmAkea Therapeutics Lung Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.12.5 PharmAkea Therapeutics Recent Developments and Future Plans
- 2.13 IQVIA
- 2.13.1 IQVIA Details
- 2.13.2 IQVIA Major Business
- 2.13.3 IQVIA Lung Disease Therapeutics Product and Solutions
- 2.13.4 IQVIA Lung Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.13.5 IQVIA Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Lung Disease Therapeutics Revenue and Share by Players (2018-2023)
- 3.2 Market Share Analysis (2022)
- 3.2.1 Market Share of Lung Disease Therapeutics by Company Revenue
- 3.2.2 Top 3 Lung Disease Therapeutics Players Market Share in 2022
- 3.2.3 Top 6 Lung Disease Therapeutics Players Market Share in 2022
- 3.3 Lung Disease Therapeutics Market: Overall Company Footprint Analysis
- 3.3.1 Lung Disease Therapeutics Market: Region Footprint
- 3.3.2 Lung Disease Therapeutics Market: Company Product Type Footprint
- 3.3.3 Lung Disease Therapeutics Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Disease Type
- 4.1 Global Lung Disease Therapeutics Consumption Value and Market Share by Disease Type (2018-2023)
- 4.2 Global Lung Disease Therapeutics Market Forecast by Disease Type (2024-2029)
5 Market Size Segment by Distribution Channel
- 5.1 Global Lung Disease Therapeutics Consumption Value Market Share by Distribution Channel (2018-2023)
- 5.2 Global Lung Disease Therapeutics Market Forecast by Distribution Channel (2024-2029)
6 North America
- 6.1 North America Lung Disease Therapeutics Consumption Value by Disease Type (2018-2029)
- 6.2 North America Lung Disease Therapeutics Consumption Value by Distribution Channel (2018-2029)
- 6.3 North America Lung Disease Therapeutics Market Size by Country
- 6.3.1 North America Lung Disease Therapeutics Consumption Value by Country (2018-2029)
- 6.3.2 United States Lung Disease Therapeutics Market Size and Forecast (2018-2029)
- 6.3.3 Canada Lung Disease Therapeutics Market Size and Forecast (2018-2029)
- 6.3.4 Mexico Lung Disease Therapeutics Market Size and Forecast (2018-2029)
7 Europe
- 7.1 Europe Lung Disease Therapeutics Consumption Value by Disease Type (2018-2029)
- 7.2 Europe Lung Disease Therapeutics Consumption Value by Distribution Channel (2018-2029)
- 7.3 Europe Lung Disease Therapeutics Market Size by Country
- 7.3.1 Europe Lung Disease Therapeutics Consumption Value by Country (2018-2029)
- 7.3.2 Germany Lung Disease Therapeutics Market Size and Forecast (2018-2029)
- 7.3.3 France Lung Disease Therapeutics Market Size and Forecast (2018-2029)
- 7.3.4 United Kingdom Lung Disease Therapeutics Market Size and Forecast (2018-2029)
- 7.3.5 Russia Lung Disease Therapeutics Market Size and Forecast (2018-2029)
- 7.3.6 Italy Lung Disease Therapeutics Market Size and Forecast (2018-2029)
8 Asia-Pacific
- 8.1 Asia-Pacific Lung Disease Therapeutics Consumption Value by Disease Type (2018-2029)
- 8.2 Asia-Pacific Lung Disease Therapeutics Consumption Value by Distribution Channel (2018-2029)
- 8.3 Asia-Pacific Lung Disease Therapeutics Market Size by Region
- 8.3.1 Asia-Pacific Lung Disease Therapeutics Consumption Value by Region (2018-2029)
- 8.3.2 China Lung Disease Therapeutics Market Size and Forecast (2018-2029)
- 8.3.3 Japan Lung Disease Therapeutics Market Size and Forecast (2018-2029)
- 8.3.4 South Korea Lung Disease Therapeutics Market Size and Forecast (2018-2029)
- 8.3.5 India Lung Disease Therapeutics Market Size and Forecast (2018-2029)
- 8.3.6 Southeast Asia Lung Disease Therapeutics Market Size and Forecast (2018-2029)
- 8.3.7 Australia Lung Disease Therapeutics Market Size and Forecast (2018-2029)
9 South America
- 9.1 South America Lung Disease Therapeutics Consumption Value by Disease Type (2018-2029)
- 9.2 South America Lung Disease Therapeutics Consumption Value by Distribution Channel (2018-2029)
- 9.3 South America Lung Disease Therapeutics Market Size by Country
- 9.3.1 South America Lung Disease Therapeutics Consumption Value by Country (2018-2029)
- 9.3.2 Brazil Lung Disease Therapeutics Market Size and Forecast (2018-2029)
- 9.3.3 Argentina Lung Disease Therapeutics Market Size and Forecast (2018-2029)
10 Middle East & Africa
- 10.1 Middle East & Africa Lung Disease Therapeutics Consumption Value by Disease Type (2018-2029)
- 10.2 Middle East & Africa Lung Disease Therapeutics Consumption Value by Distribution Channel (2018-2029)
- 10.3 Middle East & Africa Lung Disease Therapeutics Market Size by Country
- 10.3.1 Middle East & Africa Lung Disease Therapeutics Consumption Value by Country (2018-2029)
- 10.3.2 Turkey Lung Disease Therapeutics Market Size and Forecast (2018-2029)
- 10.3.3 Saudi Arabia Lung Disease Therapeutics Market Size and Forecast (2018-2029)
- 10.3.4 UAE Lung Disease Therapeutics Market Size and Forecast (2018-2029)
11 Market Dynamics
- 11.1 Lung Disease Therapeutics Market Drivers
- 11.2 Lung Disease Therapeutics Market Restraints
- 11.3 Lung Disease Therapeutics Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
- 11.5 Influence of COVID-19 and Russia-Ukraine War
- 11.5.1 Influence of COVID-19
- 11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
- 12.1 Lung Disease Therapeutics Industry Chain
- 12.2 Lung Disease Therapeutics Upstream Analysis
- 12.3 Lung Disease Therapeutics Midstream Analysis
- 12.4 Lung Disease Therapeutics Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Lung Disease Therapeutics. Industry analysis & Market Report on Lung Disease Therapeutics is a syndicated market report, published as Global Lung Disease Therapeutics Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Lung Disease Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
